The current advances and future directions of PD-1/PD-L1 blockade in head and neck squamous cell carcinoma (HNSCC) in the era of immunotherapy.

导出 LinkOut

翻译打印收藏纠错

第一作者： Yunhao,Chen

第一单位： Department of Radiation Oncology, Shandong University Cancer Center, Jinan, Shandong 250117, China; Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong 250117, China.

作者： Yunhao,Chen ^[1] ; Xingchen,Ding ^[2] ; Xinbin,Bai ^[3] ; Zihan,Zhou ^[2] ; Yu,Liu ^[4] ; Xianbin,Zhang ^[5] ; Jinming,Yu ^[6] ; Man,Hu ^[7]

作者单位： Department of Radiation Oncology, Shandong University Cancer Center, Jinan, Shandong 250117, China; Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong 250117, China. ^[1] Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong 250117, China. ^[2] Department of Radiation Oncology, Tumor Hospital of Jining, Jining, Shandong 272007, China. ^[3] Department of Oncology, Weifang Medical University, Weifang, Shandong 261053, China. ^[4] Department of General Surgery and Integrated Chinese and Western Medicine, Institute of Precision Diagnosis and Treatment of Gastrointestinal Tumors, Shenzhen University General Hospital, Shenzhen University, Shenzhen, Guangdong 518060, China. ^[5] Department of Radiation Oncology, Shandong University Cancer Center, Jinan, Shandong 250117, China; Department of Radiation Oncology and Shandong Provincial Key Laboratory of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong 250117, China; Research Unit of Radiation Oncology, Chinese Academy of Medical Sciences, Jinan, Shandong 250117, China. Electronic address: sdyujinming@126.com. ^[6] Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong 250117, China. Electronic address: human5770@163.com. ^[7]

关键词 Immunotherapy LA HNSCC PD-1/PD-L1 inhibitors R/M HNSCC

主题词人类(Humans);肿瘤复发, 局部(Neoplasm Recurrence, Local);头颈部肿瘤(Head and Neck Neoplasms);免疫疗法(Immunotherapy)

DOI 10.1016/j.intimp.2023.110329

PMID 37207445

发布时间 2023-06-16

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交